Todd Brady
Chief Executive Officer bei ALDEYRA THERAPEUTICS, INC.
Vermögen: 4 Mio $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von Todd Brady
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Dartmouth College
320
| College/University | Other Consumer Services | 320 |
| Public Company | Biotechnology | 21 | |
Southeast BIO
13
| Non-Profit Organization | 13 | |
| Subsidiary | Pharmaceuticals: Major | 11 | |
| Public Company | Pharmaceuticals: Major | 11 | |
| Public Company | Pharmaceuticals: Major | 9 | |
NovaDigm Therapeutics, Inc.
 NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND.
8
| Private Company | Pharmaceuticals: Major | 8 |
Helio Vision, Inc.
 Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Duke University School of Medicine
4
| College/University | Other Consumer Services | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Todd Brady
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member Chief Executive Officer Director/Board Member | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Citigroup Global Markets, Inc. (Broker)
 Citigroup Global Markets, Inc. (Broker) Investment Banks/BrokersFinance Citigroup Global Markets, Inc. (Broker) (CGMI-Broker) is the broker/dealer division of Citigroup Global Markets, Inc., an investment bank headquartered in New York City with additional offices across the US. The firm was founded in 2004 and is a subsidiary of Citigroup Financial Products, Inc., ultimately held by Citigroup, Inc. (NYSE: C). CGMI-Broker covers all market capitalizations of the major global indices and provides macro and quantitative analysis of global markets and sector trends. Their core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity | |
| JPMORGAN CHASE & CO. | Major Banks | Corporate Officer/Principal Corporate Officer/Principal | |
| ZOGENIX, INC. | Pharmaceuticals: Major | Founder Founder Director of Finance/CFO Director of Finance/CFO | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Meritage Pharma, Inc.
 Meritage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Meritage Pharma, Inc. develops prescription products for the treatment of gastrointestinal and atopic diseases. The company was founded by Cam L. Garner, Elaine M. Phillips and Adam K. Simpson in March 2008 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder Director/Board Member Founder | |
Aclaris Life Sciences, Inc.
 Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Medical/Nursing Services | President Director/Board Member | |
| ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree Masters Business Admin | |
| Stanford University | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| Boston University | College/University | Doctorate Degree Graduate Degree | |
| Imperial College London | College/University | Doctorate Degree Graduate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| Yale University | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Princeton University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The University of Colorado | College/University | Corporate Officer/Principal Undergraduate Degree | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Center for Global Health Innovation, Inc.
 Center for Global Health Innovation, Inc. BiotechnologyHealth Technology Center for Global Health Innovation, Inc. is a member of Georgia Bio, a non-profit life sciences association in Georgia. The non-profit company is based in Atlanta, GA. Georgia Bio works with various organizations to shape public policy, improve access to innovative technologies, and grow Georgia's life sciences economy. The CEO of the company is Maria Thacker-Goethe. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
F-star Alpha Ltd.
 F-star Alpha Ltd. BiotechnologyHealth Technology F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| XENETIC BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
F-star Biotechnology Ltd.
 F-star Biotechnology Ltd. BiotechnologyHealth Technology F-Star Biotechnology Ltd. is a biopharmaceutical company. It discovers, develops, and manufactures bispecific antibody products. The company is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
ALASTIN Skincare, Inc.
 ALASTIN Skincare, Inc. Household/Personal CareConsumer Non-Durables Alastin Skincare, Inc. develops and markets skin care products that reinvigorate, protect, and maintain healthy skin. It offers skin procedures such as injectables, laser resurfacing, microneedling, peels, photo rejuvination, radio frequency, skin tightening, surgical procedures, and ultra sound therapy. The company was founded by Scott L. Glenn and Cam L. Garner in 2015 and is headquartered in Carlsbad, CA. | Household/Personal Care | Founder Founder Director/Board Member | |
Stelis Biopharma Ltd.
 Stelis Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Stelis Biopharma Pvt Ltd. develops and manufactures pharmaceutical products. The company was founded in 2007 and is headquartered in Bangalore, India. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Tenshi Healthcare Pte Ltd.
 Tenshi Healthcare Pte Ltd. Financial ConglomeratesFinance Tenshi Healthcare Pte Ltd. is the Singaporean parent company of Biolexis Therapeutics, a clinical-stage biopharmaceutical company that develops small molecules targeting various diseases, including cancers, immune-mediated, neurodegenerative, auto-immune, metabolic, and inflammatory diseases. The private company is based in Singapore, Singapore. Biolexis uses a proprietary molecular AI-enabled drug discovery process to rapidly discover and develop novel clinical candidates. The company is also focused on building and in-licensing a portfolio of advanced biosimilars, peptides, and vaccines with a high focus on quality, affordability, and accessibility. Biolexis has a proprietary platform technology to develop and commercialize recombinant insulin and insulin analogs with high purity and consistent quality. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Chief Executive Officer Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 37 |
| Vereinigtes Königreich | 6 |
| Österreich | 3 |
| Belgien | 2 |
| Italien | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 13 |
| Finance | 7 |
| Commercial Services | 2 |
| Health Services | 2 |
Operativ
| Director/Board Member | 528 |
| Corporate Officer/Principal | 239 |
| Chairman | 97 |
| Founder | 95 |
| Independent Dir/Board Member | 95 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Garheng Kong | 60 |
| Bryan Roberts | 44 |
| Jesse I. Treu | 38 |
| Nessan Bermingham | 36 |
| Eliot Forster | 35 |
| Geeta S. Vemuri | 33 |
| Edward Benz | 29 |
| Cam Garner | 28 |
| Scott Glenn | 28 |
| Douglas Reed | 27 |
| Dana Schmaltz | 26 |
| Neal Walker | 24 |
| Mike Gutch | 24 |
| Darlene M. Deptula-Hicks | 24 |
| Kenneth Widder | 24 |
- Börse
- Insiders
- Todd Brady
- Unternehmensverbindungen
